Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy
Condition(s) studied
Investigational drug(s) / intervention(s)
Costotransverse foramen block: Patients will receive an ipsilateral ultrasound-guided costotransverse foramen block with injection of 20 ml bupivacaine 0.25%.
Erector spinae plane block: Patients will receive an ipsilateral ultrasound-guided erector spinae plane block with injection of 20 ml bupivacaine 0.25%.
Study summary
This study aims to compare the costotransverse foramen block with erector spinae plane block in modified radical mastectomy.
Eligibility
Primary outcome measure(s)
- Total morphine consumption — 24 hours postoperatively
If the numeric rating scale (NRS) is ≥ 4, an IV morphine dose (3 mg) will be provided Paracetamol 1 gm and ketorolac 30 mg will be administered every 8 hours postoperatively.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Cairo University | Cairo | Egypt | Recruiting |
More National Cancer Institute, Egypt trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07367568 on ClinicalTrials.gov ↗ ← All trials in Egypt